Literature DB >> 19250130

Editorial: On the benefits of modeling using QALYs for societal resource allocation: the model is the message.

Louis P Garrison.   

Abstract

Mesh:

Year:  2009        PMID: 19250130     DOI: 10.1111/j.1524-4733.2009.00520.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  4 in total

1.  Regulatory benefit-risk assessment and comparative effectiveness research: strangers, bedfellows or strange bedfellows?

Authors:  Louis P Garrison
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study.

Authors:  Joshua A Roth; Ruth Etzioni; Teresa M Waters; Mary Pettinger; Jacques E Rossouw; Garnet L Anderson; Rowan T Chlebowski; Joann E Manson; Mark Hlatky; Karen C Johnson; Scott D Ramsey
Journal:  Ann Intern Med       Date:  2014-05-06       Impact factor: 25.391

3.  Stakeholder perspectives on a risk-benefit framework for genetic testing.

Authors:  Joshua A Roth; Louis P Garrison; Wylie Burke; Scott D Ramsey; Rick Carlson; David L Veenstra
Journal:  Public Health Genomics       Date:  2010-04-20       Impact factor: 2.000

Review 4.  Assessing the value of orphan drugs using conventional cost-effectiveness analysis: Is it fit for purpose?

Authors:  Maarten J Postma; Declan Noone; Mark H Rozenbaum; John A Carter; Marc F Botteman; Elisabeth Fenwick; Louis P Garrison
Journal:  Orphanet J Rare Dis       Date:  2022-04-05       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.